Εμφάνιση απλής εγγραφής

dc.creatorAthanasiou L.V., Papatsiros V.G., Spanou V.M., Katsogiannou E.G., Dedousi A.en
dc.date.accessioned2023-01-31T07:34:03Z
dc.date.available2023-01-31T07:34:03Z
dc.date.issued2021
dc.identifier10.3390/microorganisms9051097
dc.identifier.issn20762607
dc.identifier.urihttp://hdl.handle.net/11615/70924
dc.description.abstractNeospora caninum and Toxoplasma gondii affect both humans and animals worldwide. To investigate their seroprevalence and differences in seropositivity between pigs vaccinated and unvac-cinated against porcine circovirus 2 (PCV2), as well as differences in muscle enzyme activity between seropositive and seronegative pigs, blood samples were collected from 380 sows. Antibodies against T. gondii and N. caninum were detected by an indirect immunofluorescence antibody (IFA) assay, while the activities of creatine kinase (CK) and aspartate aminotransferase (AST) were biochemically assessed. Out of the 364 sows finally included in the study, 4.4%, 3.5%, and 0.5% were seropositive to T. gondii, N. caninum, or both. A significantly higher percentage of seropositivity against T. gondii and/or N. caninum in PCV2 unvaccinated pigs compared with vaccinated pigs was observed. In-creased serum activities of CK and AST were detected in 71.43% and 100% of only against T. gondii (T+) and 63.64% and 90.91% of only against N. caninum (N+) seropositive sows, respectively, and were significantly higher compared to seronegative animals. T. gondii and N. caninum seropositivity, especially in presumed immunocompromised pigs, and the evidence of muscle damage highlight their importance as a zoonotic pathogen and animal model of human infection, respectively. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.en
dc.language.isoenen
dc.sourceMicroorganismsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85106161964&doi=10.3390%2fmicroorganisms9051097&partnerID=40&md5=f3fc373b2493e82ff34f7fc513cd1074
dc.subjectMDPI AGen
dc.titleNeospora caninum and/or toxoplasma gondii seroprevalence: vaccination against pcv2 and muscle enzyme activity in seropositive and seronegative pigsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής